PROGRAM
Scientific Program
Program
Scientific Program
  • Program at a Glance
  • Scientific Program
  • Invited Speakers & Moderators
Scientific Program

April. 26(Fri)

April. 27(Sat)

  • April. 26(Fri),
  • 08:30-09:40 KST
  • Master Class
  • Room 5A Hall
  • Chair(s)
  • Yong Man Kim (Ulsan University, Korea)
  • Takayuki Enomoto (Niigata University, Japan)
  • 08:30 - 08:50
  • AI-enhanced pathology: pathway to precision in oncology
  • SooIck Cho (Lunit Inc., Korea)
  • 08:50 - 09:00
  • Designated discussion
  • Sung Taek Park (Hallym University, Korea)
  • 09:00 - 09:05
  • Floor discussion
  • 09:05 - 09:25
  • Locally advanced cervical cancer management
  • Dimitrios Nasioudis (University of Pennsylvania, USA)
  • 09:25 - 09:35
  • Designated discussion
  • Tae-Wook Kong (Ajou University, Korea)
  • 09:35 - 09:40
  • Floor discussion
  • April. 26(Fri),
  • 09:50-10:50 KST
  • Plenary I: Scientific Oral Session
  • Room 5A Hall
  • Chair(s)
  • Dong-Choon Park (Catholic University, Korea)
  • Mikio Mikami (Tokai University, Japan)
  • 09:50 - 10:00
  • A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treatted with a PARP inhibitor (KGOG 3056/NIRVANA-R)
  • Hyun-Woong Cho (Korea University, Korea)
  • 10:00 - 10:05
  • Distillate discussion
  • Sung Jong Lee (Catholic University, Korea)
  • 10:05 - 10:10
  • Floor discussion
  • 10:10 - 10:20
  • Predicting microsatellite instability status in endometrial cancer using F-18 Fluorodeoxyglucose positron emission tomography/computed tomography radiomics
  • Jong Mi Kim (Kyungpook National University, Korea)
  • 10:20 - 10:25
  • Distillate discussion
  • Yong Jae Lee (Yonsei University, Korea)
  • 10:25 - 10:30
  • Floor discussion
  • 10:30 - 10:40
  • Oncologic outcomes and the Impact of minimally Iivasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: a korean gynecologic oncology group study (KGOG 1048)
  • Dae-Yeon Kim (Ulsan University, Korea)
  • 10:40 - 10:45
  • Distillate discussion
  • Dimitrios Nasioudis (University of Pennsylvania, USA)
  • 10:45 - 10:50
  • Floor discussion
  • April. 26(Fri),
  • 11:10-12:10 KST
  • Plneary II: Scientific Oral Session
  • Room 5A Hall
  • Chair(s)
  • Jae Kwan Lee (Korea University, Korea)
  • Yang Xiang (Peking Union Medical College, China)
  • 11:10 - 11:20
  • Development of a novel ex-vivo anticancer drug screening system for precision medicine in ovarian cancer patients
  • Jeong-Won Lee (Sungkyunkwan University, Korea)
  • 11:20 - 11:25
  • Distillate discussion
  • Jae Hong No (Seoul National University, Korea)
  • 11:25 - 11:30
  • Floor discussion
  • 11:30 - 11:40
  • Analysis of improvement in overall survival rate when cervical cancer patients participate in clinical trials
  • Yong Man Kim (Ulsan University, Korea)
  • 11:40 - 11:45
  • Distillate discussion
  • Hiroaki Kobayashi (Kagoshima University, Japan)
  • 11:45 - 11:50
  • Floor discussion
  • 11:50 - 12:00
  • Emerging role of immuno-oncologics in cervical cancer
  • Yang Xiang (Peking Union Medical College, China)
  • 12:00 - 12:05
  • Distillate discussion
  • So-Jin Shin (Keimyung University, Korea)
  • 12:05 - 12:10
  • Floor discussion
  • April. 26(Fri),
  • 12:10-12:40 KST
  • Industry Session I
  • Room 5A Hall
  • Chair(s)
  • Soo-Young Hur (Catholic University, Korea)
  • Tae Jin Kim (Konkuk University, Korea)
  • 12:10 - 12:25
  • Enhancing HPV management through risk stratification: the role of dual staining with p16 and Ki-67
  • Kyung-Jin Min (Korea University, Korea)
  • 12:25 - 12:40
  • Illuminating for EC patients: unveiling a new treatment para-digm in 1L EC
  • Kidong, Kim (Seoul National University, Korea)
  • April. 26(Fri),
  • 13:30-14:10 KST
  • Focused Plenary-Ovary I
  • Room 5A Hall
  • Chair(s)
  • Suk-Joon Chang (Ajou University, Korea)
  • Jeong-Won Lee (Sungkyunkwan University, Korea)
  • 13:30 - 13:38
  • Distinct immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancer
  • Junsik Park (Soonchunhyang University, Korea)
  • 13:38 - 13:46
  • A comprehensive proteomics study to predict therapeutic responses to PARP inhibitors in high-grade serous ovarian cancer
  • Se Ik Kim (Seoul National University, Korea)
  • 13:46 - 13:54
  • Development of a next-generation RNA sequencing-based deep-learning model predicting risk of chemoresistance in high-grade serous ovarian carcinoma
  • Se Ik Kim (Seoul National University, Korea)
  • 13:54 - 14:02
  • Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis
  • Young-Jae Lee (Ulsan University, Korea)
  • 14:02 - 14:10
  • Floor discussion
  • April. 26(Fri),
  • 14:10-14:50 KST
  • Focused Plenary-Ovary II
  • Room 5A Hall
  • Chair(s)
  • Ju-Won Roh (CHA University, Korea)
  • Sunghoon Kim (Yonsei University, Korea)
  • 14:10 -14:18
  • Surgical outcomes of interval debulking surgery after neoadjuvant chemoimmunotherapy for advanced-stage ovarian cancer
  • Dahye Lee (Yonsei University, Korea)
  • 14:18 - 14:26
  • Effect of Quality Control Program on Surgical Management in Advanced Ovarian Cancer
  • Bo Ra Kim (Ewha Womans University, Korea)
  • 14:26 - 14:34
  • FOXA1 FOXA1 gene that plays an important role in ovarian cancerthat plays an important role in ovarian cancer
  • Eunjung Yang (Soonchunhyang University, Korea)
  • 14:34 - 14:42
  • Hyperthermic intraperitoneal chemotherapy for stage IV epithelial ovarian cancer: a critical appraisal of indications and clinical implications
  • Joo-Hyuk Son (Ajou University, Korea)
  • 14:42 - 14:50
  • Floor discussion
  • April. 26(Fri),
  • 13:30-14:10 KST
  • Focused Plenary-Uterine Corpus
  • Room 321+322+323+324
  • Chair(s)
  • Jae-Hoon Kim (Yonsei University, Korea)
  • Dae Hoon Jeong (Inje University, Korea )
  • 13:30 - 13:38
  • Investigating L1CAM and β-catenin as Prognostic Indicators in Fertility-Sparing Endometrial Cancer Treatment
  • Jeong-Yeol Park (Ulsan University, Korea)
  • 13:38 - 13:46
  • Hormone replacement therapy and risks of various cancers in postmenopausal women with de-novo or a history of endometriosis
  • Banghyun Lee (Inha University, Korea)
  • 13:46 - 13:54
  • Improving preoperative identification of uterine sarcomas: analysis of clinical and imaging Characteristics
  • Seungmee Lee (Keimyung University, Korea)
  • 13:54 - 14:02
  • Correlation between mismatch repair status and lymph node metastasis in endometrial cancer
  • Minjeong Park (Inje University, Korea)
  • 14:02 - 14:10
  • Floor discussion
  • April. 26(Fri),
  • 14:10-14:50 KST
  • Focused Plenary-Cervix
  • Room 321+322+323+324
  • Chair(s)
  • Sang Young Ryu (Korea Cancer Center, Korea)
  • Dae-Yeon Kim (Ulsan University, Korea)
  • 14:10 -14:18
  • Optimal dietary intake of riboflavin associated with lower risk of cervical cancer in korea : korean national health and nutrition examination survey 2010-2021
  • Seon-Mi Lee (Korea University, Korea)
  • 14:18 - 14:26
  • Impact of metformin on survival outcome in advanced cervical cancer: A Korean and Japanese Gynecologic Oncology Group (KGOG & JGOG) collaboration study
  • Min-Hyun Baek (Kangwon National University, Korea)
  • 14:26 - 14:34
  • A feasibility study of upcycled smartphone-based colposcopy for visual inspection of cervix performed by community healthcare workers in rural Vietnam
  • Ga Won Yim (Dongguk University, Korea)
  • 14:34 - 14:42
  • A tissue factor bi-specific T cell engager provides effective targeting and cytotoxicity against cervical cancer cell lines
  • Hye-yon Cho (Hallym University, Korea)
  • 14:42 - 14:50
  • Floor discussion
  • April. 26(Fri),
  • 15:20-16:00 KST
  • Focused Plenary-Others
  • Room 5A Hall
  • Chair(s)
  • Jong-Min Lee (Kyung Hee University, Korea)
  • Seob Jeon (Soonchunhyang University, Korea)
  • 15:20 - 15:28
  • Assessing adverse pregnancy outcomes and fetal malformations in cancer diagnosed during pregnancy
  • Yung-Taek Ouh (Korea University, Korea)
  • 15:28 -15:36
  • Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years
  • Taehyun Kim (Konyang University, Korea)
  • 15:36 - 15:44
  • Lymphedema in gynecological cancer survivor ; a nationwide cohort study - Withdrawal
  • Su Jeong Lee (Catholic University, Korea)
  • 15:44 - 15:52
  • Preliminary study of combination treatment of immune checkpoint inhibitors and modulated electro-hyperthermia in recurrent gynecologic malignancies
  • Jihyun Moon (CHA University, Korea)
  • 15:52 - 16:00
  • Floor discussion
  • April. 26(Fri),
  • 13:30-14:50 KST
  • Overseas Session
  • Room 121+122
  • Chair(s)
  • Ga Won Yim (Dongguk University, Korea)
  • Hiroaki Kobayashi (Kagoshima University, Japan)
  • 13:30 - 13:38
  • Comparison of survival outcomes between sequential and ‘sandwich’ sequencing of adjuvant chemo-radiotherapy in advanced stage endo metrial carcinoma patients at phramongkutklao hospital and national cancer institute
  • Ekasit Chaiamonsup (Phramongkutklao Hospital, Thailand)
  • 13:38 - 13:40
  • Floor discussion
  • 13:40 - 13:48
  • Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II trial
  • Chen Li (Peking Union Medical College, China)
  • 13:48 - 13:50
  • Floor discussion
  • 13:50 - 13:58
  • UBE2T-mediated stemness enhancement: unraveling platinum resistance mechanisms in ovarian cancer
  • Jingying Chen (Shandong University, China)
  • 13:58 - 14:00
  • Floor discussion
  • 14:00 - 14:08
  • Estrogen Receptor Downregulates Programmed Death Ligand-1 and Associated with Clinicopathological of type 1 Endometrial Carcinoma
  • Setyo Teguh Waluyo (Lambung Mangkurat University, Indonesia)
  • 14:08 - 14:10
  • Floor discussion
  • 14:10 - 14:18
  • Stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response
  • Jumpei Ogura (Kyoto University, Japan)
  • 14:18 - 14:20
  • Floor discussion
  • 14:20 - 14:28
  • Factors influencing single agent methotrexate chemotherapy resistance in low risks gestational trophoblastic neoplasia in indonesia single center trophoblast study
  • Febia Erfiandi (Padjadjaran University, Indonesia)
  • 14:28 - 14:30
  • Floor discussion
  • 14:30 - 14:38
  • Survival in patients with recurrent or progressive uterine carcinosarcoma
  • Kanakarn Wangrangsimakul (Songkhlanagarind Hospital, Thailand)
  • 14:38 - 14:40
  • Floor discussion
  • 14:40 - 14:48
  • Trends and outcomes of minimally invasive surgery for endometrial cancer in kanagawa academic institutions: a retrospective observational study
  • Jun Takeuchi (St. Marianna University, Japan)
  • 14:48 - 14:50
  • Floor discussion
  • April. 26(Fri),
  • 15:20-16:00 KST
  • AI in Gyn Oncology
  • Room 321+322+323+324
  • Chair(s)
  • Sung Jong Lee (Catholic University, Korea)
  • Banghyun Lee (Inha University, Korea)
  • 15:20 - 15:30
  • Pelvic ultrasound-based deep learning models for accurate diagnosis of ovarian cancer: retrospective multicenter study
  • Hyun-Woong Cho (Korea University, Korea)
  • 15:30 - 15:33
  • Floor discussion
  • 15:33 - 15:43
  • Prognostic implications of body composition in cervical cancer patients who underwent concurrent chemoradiation therapy as a primary treatment: a clinical research utilizing an artificial intelligence-based volumetrics
  • Hyunji Lim (CHA University, Korea)
  • 15:43 - 15:46
  • Floor discussion
  • 15:46 - 15:56
  • Practical Use of ChatGPT and Generative AI on Clinical Research
  • Jeong-Moo Lee (Seoul National University, Korea)
  • 15:56 - 16:00
  • Floor discussion
  • April. 26(Fri),
  • 15:20-16:00 KST
  • SHAPE
  • Room 121+122
  • Chair(s)
  • Sokbom Kang (National Cancer Center, Korea)
  • Won Moo Lee (Hanyang University, Korea)
  • 15:20 - 15:30
  • On the radical hysterectomy
  • Yusuke Kobayashi (Keio University, Japan)
  • 15:30 - 15:40
  • Pros
  • Se Ik Kim (Seoul National University, Korea)
  • 15:40 - 15:50
  • Cons
  • Jeong-Yeol Park (Ulsan University, Korea)
  • 15:50 - 16:00
  • Floor discussion
  • April. 26(Fri),
  • 16:40-17:40 KST
  • Multidisciplinary Tumor board for Cervical Cancer
  • Room 5A Hall
  • Chair(s)
  • Yoo-Young Lee (Sungkyunkwan University, Korea)
  • Youn Jin Choi (Catholic University, Korea)
  • 16:40-17:40
  • Advancing Treatment for HPV-Independent Cervical Cancer and Enhancing CCRT Outcomes
  • Hyun-Soo Kim (Sungkyunkwan University, Korea)
  • Ji Ho Nam (Pusan National Univeristy, Korea)
  • Sung Taek Park (Hallym University, Korea)
  • Ji Hye Kim (Chung-Ang University, Korea)
  • April. 26(Fri),
  • 16:10-17:40 KST
  • Nursing Session
  • Room 321+322+323+324
  • Chair(s)
  • Gie Ok Noh (Konyang University, Korea)
  • Dong Soo Suh (Pusan University, Korea)
  • 16:10-16:30
  • Application of targeted therapy and Immunotherapy in gynecological cancer treatment
  • Sun Young Yu (Asan Medical Center)
  • 16:30-16:50
  • 표적*면역 항암제 적용에 따른 부작용 관리
  • Joohyun Kim (Samsung Medical Center)
  • 16:50-17:10
  • 가임력 보존을 희망하는 젊은 부인암 환자 관리
  • Hyun-Woong Cho (Korea University, Korea)
  • 17:10-17:30
  • 부인암 생존자의 재활과 운동
  • Heoungsu Kim (Korea Cancer Rehabilitation lnstitute, Korea)
  • 17:30-17:40
  • Discussion
  • 17:40
  • 폐회사
  • 노기옥 간호분과장 (건양대학교)
  • April. 26(Fri),
  • 16:00-16:30 KST
  • Featured Poster - Line 1
  • Line 1 at the backside of 5A Hall
  • Moderator(s)
  • Sang-Il Park (DIRAMS Cancer Center, Korea)
  • 16:00 - 16:05
  • The efficacy of subsequent chemotherapy in ovarian cancer patients who progressed in prior PARPi
  • Jung Chul Kim (Yonsei University, Korea)
  • 16:05 - 16:10
  • Anti-cancer effect of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer
  • Jeong-Won Lee (Sungkyunkwan University, Korea)
  • 16:10 - 16:15
  • Application of Machine Learning Algorithms for Risk Stratification and Efficacy Evaluation in Cervical Cancer Screening among Low- Grade Abnormal Cytology Population: Evidence from the Korean HPV Cohort Study
  • Heekyoung Song (Catholic University, Korea)
  • April. 26(Fri),
  • 16:15-16:20 KST
  • Featured Poster - Line 2
  • Line 2 at the backside of 5A Hall
  • 16:15 - 16:20
  • Risk factors for the recurrence in patients with early endometrioid endometrial cancer achieving complete remission for fertility-sparing hormonal treatment
  • Eun Bi Jang (Konkuk University, Korea)
  • April. 26(Fri),
  • 16:20-16:25 KST
  • Featured Poster - Line 1
  • Line 1 at the backside of 5A Hall
  • 16:20 - 16:25
  • Consideration of Fertility-Preserving Treatment for Cervical Cancer Based on the Evolution
  • Masato Tamate (Sapporo Medical University, Japan)
  • Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer-Withdrawal
  • Yoo-Na Kim (Yonsei University, Korea)
  • Development of a next-generation sequencing cancer panel‐based homologous recombination deficiency test in epithelial ovarian cancer - Withdrawal
  • Se Ik KIM (Seoul National University, Korea)
  • ZBTB8A promotes ovarian cancer metastasis through interacting with ACOT12 - Withdrawal
  • Zhang Jinging (Shandong University, China)
  • April. 26(Fri),
  • 16:00-16:30 KST
  • Featured Poster - Line 2
  • Line 2 at the backside of 5A Hall
  • Moderator(s)
  • Taek Sang Lee (Seoul National University, Korea)
  • 16:00 - 16:05
  • Identification of Tumor-Specific Genes in Cervix sample of Ovarian Cancer Patients
  • Chi-Son Chang (Chung-Ang University, Korea)
  • 16:05 - 16:10
  • A phase 1/2a, dose-escalation, safety, and preliminary efficacy randomized trial of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2
  • Sohyeon Jeong (Korea University. Korea)
  • 16:10 - 16:15
  • Usefulness of magnetic resonance imaging before hysterectomy in detecting occult invasive cervical cancer in patients scheduled for hysterectomy due to high-grade and microinvasive cervical disease
  • Jimin Lee (Ajou University, Korea)
  • 16:15 - 16:20
  • Multicenter Retrospective Analysis of Neuroendocrine Carcinoma of the Cervix: Clinical Behavior, Treatment Patterns, and Prognostic Outcomes.
  • Takuya Kuboya (University of Tsukuba, Japan)
  • 16:20 - 16:25
  • Combined oral contraceptives and endometrial cancer among Southeast Asian women: A secondary analysis of multicenter case-control study
  • Kuntima Kantawee (Khon Kaen University, Thailand)
  • 16:25 - 16:30
  • KNOWLEDGE OF HUMAN PAPILLOMAVIRUS VACCINE AND INFECTION IN SECONDARY SCHOOL STUDENTS FROM NORTHERN THAILAND: POST COVID-19 ERA.
  • Napat Likkasittipan (Chiang Mai University, Thailand)